Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

EMA Public Hearings On Marketed Medicines To Start Next Year

Executive Summary

The European Medicines Agency is set to give EU citizens a voice in the safety evaluation of marketed medicines by holding its first public hearing next year, though no specific topic or date has been decided.

Advertisement

Related Content

Waiting For The Perfect Case: Why EMA Has Yet To Hold A Public Drug Safety Hearing
Don't Let Sponsors Downplay Genuine Safety Concerns At Public Hearings, HAI Tells EMA

Topics

Advertisement
UsernamePublicRestriction

Register

PS119281

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel